Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - February 2013

Lyophilisation: Freeze-Drying in Pharmaceuticals and Biopharmaceuticals

25 Feb 2013 - 26 Feb 2013 - London, UK

Bookmark and Share

SMi is proud to present their inaugural conference on Lyophilisation: Freeze-drying in pharmaceuticals & Biopharmaceuticals, with key talks from Medimmune, GSK Biologicals, National Institute for Biological Standards & Control and Roche on the best practices, novel discoveries and industry innovations that are essential to the development of a company’s lyophilisation process. This conference is not to be missed as this is the forum for you to learn, explore and discover the cutting edge areas of the industry, and the essential ways a company can improve its freeze drying methods.

Benefits of attending include:                                                                         Learn of formulation techniques that assist in the lyophilisation process, and how to apply these to your own technical issues

·         Explore the latest research and development in the industry, and how these have led to improved lyophilisation cycles, both pre, and post up-scaling

·         Discover the potential technical and logistical difficulties encountered in all levels of the lyophilisation process

·         Consider the regulations in chemical engineering and how compliance can be achieved

·         Examine previous examples of up-scaling in the industry, and how to apply these to your own freeze-drying process

·         Hear about regulations, monitoring and risk reduction, to improve the cost effectiveness of the cycle, and how these can be used to manage risks and adapt to the problems encountered

Key speakers include:

 Yves Mayeresse, Director of Manufacturing, GSK Biologicals

·         Sajal Patel, Scientist II, MedImmune

·         Patrick Garidel, Head of Pharmaceutical Basic Development, Boehringer Ingelheim

·         Paul Matejtschuk, Principal Scientist, National Institute For Biological Standards & Control

Sune Klint Andersen, Principal Scientist Drying Processes, Novo Nordisk A/s          

       Jean René Authelin, Global Head of Pharmaceutical Engineering, Pharmaceutical Sciences, Sanofi R&D

·         Ahmad Abdul-Fattah, Group Leader, Late Stage Pharmaceutical and Processing Development, Roche

 Register at

Or alternatively contact Annie Blundell on tel +44 (0)20 7827 6090 or email:

Further information
Scientific News
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Chemical Design Made Easier
Rice University scientists prepare elusive organocatalysts for drug and fine chemical synthesis.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Fighting Pain with Ketamine
Researchers at the Texas A&M Health Science Center are using ketamine, a drug that already exists as an anesthetic, to treat pain.
Possible New Treatment for Neurodegenerative Diseases Found
Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be used as a treatment for neurodegenerative diseases.
Breast Cancer Drug Beats Superbug
Tamoxifen helps white blood cells clear multidrug-resistant bacteria in lab and mouse studies.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos